Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,957 total articles

YXT.com Reports Full Year 2025 Unaudited Financial Results

YXT.com Reports Full Year 2025 Unaudited Financial Results

YXT.com Group Holding Limited reported its unaudited financial results for the full year ended December 31, 2025, revealing a 2.7% increase in total revenues to RMB340.2 million (US$48.7 million), and a significant improvement in gross margin to 68.3% driven by cost efficiencies and strategic focus on AI-enhanced corporate learning solutions. Despi…

Bitfarms Reports Fiscal Year 2025 Results

Bitfarms Reports Fiscal Year 2025 Results

Bitfarms Ltd. reported strong fiscal year 2025 results, showcasing significant revenue growth and advancement in its strategic pivot from Bitcoin mining to high-performance computing (HPC) infrastructure focused on AI workloads. The company secured shareholder approval to redomicile from Canada to the U.S. and rebrand as Keel Infrastructure, markin…

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology

Biogen is acquiring Apellis Pharmaceuticals for approximately $5.6 billion in cash plus contingent value rights, gaining two FDA-approved immunology and rare disease medicines, EMPAVELI and SYFOVRE. The acquisition is expected to enhance Biogen's growth prospects by adding immediate revenues of $689 million in 2025 from Apellis' products, accelerat…

La Rosa Holdings Adds Over $6.4 Million in Net Assets to Balance Sheet as Part of Digital Asset Treasury to Scale AI Infrastructure Strategy

La Rosa Holdings Adds Over $6.4 Million in Net Assets to Balance Sheet as Part of Digital Asset Treasury to Scale AI Infrastructure Strategy

La Rosa Holdings Corp. announced the addition of $6.4 million in net assets from its digital asset treasury strategy to enhance liquidity for expanding its AI infrastructure and real estate portfolio. The Company plans to acquire land in Osceola County, Florida, for a Tier III AI data center and intends to acquire Consensus Core Technologies, a pro…

AH Realty Trust Advances Strategic Transformation Through Sale of Two Multifamily Real Estate Financing Investments

AH Realty Trust Advances Strategic Transformation Through Sale of Two Multifamily Real Estate Financing Investments

AH Realty Trust has sold two multifamily notes for $63 million as part of its strategic exit from real estate financing, aiming to simplify its platform and focus on core retail and office assets. The company plans to use proceeds to pay down debt and support its share repurchase program, having already repurchased approximately 3.6 million shares …

T1 Energy Reports Fourth Quarter and Full-Year 2025 Results

T1 Energy Reports Fourth Quarter and Full-Year 2025 Results

T1 Energy Inc. (NYSE: TE) announced its fourth quarter and full-year 2025 financial results, highlighting significant progress in the construction of its G2_Austin 2.1 GW solar cell fab, on track for Q4 2026 production start. The company achieved record quarterly module production and sales at its G1_Dallas facility in Q4 2025, expanded utility-sca…

AGA Precision Systems Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products

AGA Precision Systems Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products

AGA Precision Systems, a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB), has signed a long-term agreement to supply mission-critical aerospace and defense components to Turbo-Jet Products. The agreement spans an initial five years with options for renewal, reinforcing AGA's strategic role in the aerospace and defense supply chain, supported by its…

MiNK Therapeutics Reports Q4 and Full Year 2025 Results; Phase 2 Programs Advance with Impactful Non-Dilutive Momentum

MiNK Therapeutics Reports Q4 and Full Year 2025 Results; Phase 2 Programs Advance with Impactful Non-Dilutive Momentum

MiNK Therapeutics reported their Q4 and full-year 2025 financial results, highlighting significant progress in their iNKT cell therapy pipeline targeting severe immune-mediated diseases such as ARDS, pulmonary fibrosis, cancer, and GVHD. The company secured non-dilutive funding from collaborations and grants, advanced multiple clinical programs, an…